PRGO Perrigo: Nilai bisnis marang pendapatan

Logo perusahaan publik Perrigo (PRGO)

Rising demand for budget pharmaceuticals and debt reduction at Perrigo Company plc (PRGO) are influencing the EV/Sales multiple trajectory, where the value has stabilized at 1281.85. The company's revenues are based on wholesale supplies of private label products to global chains and supermarkets. Simultaneously, management is optimizing the asset structure to drive profit growth, which supports the business's market value relative to its revenue.

Perrigo Company plc - Multiplikator EV/Sales PRGO (periode 23.11.2025 - 20.11.2026)

PRGO (perrigo.com): rincian analitis lan laporan miturut indikator

- rega lan prakiraan konsensus rega:
- data kapitalisasi saham perusahaan:
Pambiji fundamental:Perrigo Company plc PRGO
Produk mawa merek Perrigo Company plc

This indicator determines the market value of the business including net debt per unit of revenue, allowing for an assessment of revenue generation efficiency regardless of financial leverage. By analyzing changes in the EV/Sales ratio, an investor can see how the market is revaluing the capitalization of Perrigo Company plc (PRGO) during its strategic pivot toward the OTC segment and the optimization of supply chains to improve margins.

Analisis pesaing Perrigo Company plc

HLN: Rasio nilai perusahaan marang pendapatan|Kenvue Corp (KVUE) - Rasio nilai perusahaan marang pendapatan|Verona Pharma PLC - Nilai bisnis marang pendapatan|Rasio nilai perusahaan marang pendapatan Jyong Biotech Ltd|Multiplikator EV/Sales Ligand Corp|Multiplikator EV/Sales AMRX|Koefisien nilai perusahaan marang pendapatan ALVO|Multiplikator EV/Sales LQDA (Liquidia Technologies)|Multiplikator EV/Sales Galapagos GLPG|ANI Pharmaceuticals Inc - Multiplikator EV/Sales|MNKD (MannKind Corp.) - Rasio nilai perusahaan marang pendapatan|AMPH: Multiplikator EV/Sales|PCRX (Pacira BioSciences) - Rasio nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan ARS Pharmaceuticals Inc|Nilai perusahaan marang pendapatan Theravance Biopharma, Inc. (TBPH)|Nilai perusahaan marang pendapatan AQST (Aquestive Pharma)|SCPH - Multiplikator nilai perusahaan marang pendapatan|Multiplikator EV/Sales TECX (Tectonic Therapeutic, Inc.)|TNXP - Nilai perusahaan marang pendapatan|China SXT Pharmaceuticals, Inc. - Multiplikator EV/Sales|EPRX - Multiplikator EV/Sales|BHST: Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan eXoZymes Inc (EXOZ)|ORMP (oramed.com) - Multiplikator EV/Sales|Rasio nilai perusahaan marang pendapatan ENTX (Entera Bio)|Rasio nilai perusahaan marang pendapatan MindWalk (HYFT)|Multiplikator EV/Sales ABVC BioPharma, Inc. (ABVC)|Rasio nilai perusahaan marang pendapatan Cumberland Corp CPIX|QNTM - Nilai perusahaan marang pendapatan|FGEN - Rasio nilai perusahaan marang pendapatan|TELO - Multiplikator EV/Sales|Rani Therapeutics Inc (RANI) - Rasio nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan SNYR|Rasio nilai perusahaan marang pendapatan Rallybio Corp|Rasio nilai perusahaan marang pendapatan LEXX|Multiplikator EV/Sales PULM|PTHL: Nilai perusahaan marang volume dodolan|Multiplikator EV/Sales APM (Aptorum Group Ltd)|LYRA - Nilai perusahaan marang pendapatan|Impact BioMedical Inc - Multiplikator EV/Sales|Nilai perusahaan marang volume dodolan TNFA|YCBD (cbdmd.com) - Nilai perusahaan marang pendapatan|painreform.com - Nilai bisnis marang pendapatan|Nilai perusahaan marang pendapatan CYTO|Rasio nilai perusahaan marang pendapatan LIPO|Rasio nilai perusahaan marang pendapatan optinose.com (OPTN)|PIRS (Pieris Pharma) - Nilai bisnis marang pendapatan|Rasio nilai perusahaan marang pendapatan Procaps Group S.A. PROC|Rasio total nilai perusahaan marang pendapatan petrospharma.com (PTPI)|QLI - Rasio nilai perusahaan marang pendapatan|Nilai bisnis marang pendapatan SLRN (ACELYRIN)|TFF Pharmaceuticals, Inc (TFFP) - Rasio nilai perusahaan marang pendapatan